Genetic methods of polymer synthesis have become an increasingly prominent strategy for the synthesis of well‐controlled polymer architectures. The exact control of molecular weight and sequence of protein biosynthesis permits the production of protein‐based polymers in which functional group placement can be controlled on the angstrom length scale and for which hierarchical assembly affords structural control on the macroscopic length scale. Protein polymers, produced via protein engineering strategies, have captured many of the sequence, structural, and functional properties of naturally occurring structural proteins such as silk, collagen, and elastin. Artificial proteins with sequences designed
de novo
have also been shown to form well‐controlled lamellar crystalline structures, liquid crystalline phases, and reversible hydrogels. The incorporation of nonnatural amino acids into protein polymers has further expanded their chemical versatility; appropriate engineering of the protein expression host permits the incorporation of alkenes, alkynes, azides, ketones, aryl halides, and other functional groups. The strategies permit the production of polymers for research and commercial applications including drug delivery, vascular graft engineering, tissue engineering, and high performance materials.